Ki67 and BUBR1 May Discriminate Clinically Insignificant Prostate Cancer in the PSA Range <4 ng/ml (Q53160720)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 12, 2011

edit

Language	Label	Description	Also known as
English	Ki67 and BUBR1 May Discriminate Clinically Insignificant Prostate Cancer in the PSA Range <4 ng/ml	scientific article published on January 12, 2011

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

title

Ki67 and BUBR1 May Discriminate Clinically Insignificant Prostate Cancer in the PSA Range &lt;4 ng/ml (English)

reason for preferred rank

most precise value

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Ki67 and BUBR1 may discriminate clinically insignificant prostate cancer in the PSA range <4 ng/ml (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21233104

retrieved

22 November 2024

author name string

Kazuhiro Nagao

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

Yoshiaki Yamamoto

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

Tomohiko Hara

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

Hirotaka Komatsu

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

Ryo Inoue

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

Kenji Matsuda

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

Hiroaki Matsumoto

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

Takahiko Hara

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

Shigeru Sakano

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

Yoshikazu Baba

series ordinal

10

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

Hideyasu Matsuyama

series ordinal

11

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

language of work or name

English

1 reference

stated in

National Center for Biotechnology Information

PubMed publication ID

21233104

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21233104

retrieved

22 November 2024

publication date

12 January 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

full work available at URL

http://jjco.oxfordjournals.org/cgi/content/abstract/41/4/555

online access status

open access

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21233104

retrieved

22 November 2024

http://academic.oup.com/jjco/article-pdf/41/4/555/5268820/hyq233.pdf

file format

PDF

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

published in

Japanese Journal of Clinical Oncology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

volume

41

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

page(s)

555-564

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

cites work

Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination. Enhancement of specificity with free PSA measurements

series ordinal

1

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Prospective detection of clinically relevant prostate cancer in the prostate specific antigen range 1 to 3 ng./ml. combined with free-to-total ratio 20% or less: the Aarau experience.

series ordinal

2

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features

series ordinal

4

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Influence of age and prostate-specific antigen on the chance of curable prostate cancer among men with nonpalpable disease

series ordinal

5

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Characteristics of insignificant clinical T1c prostate tumors. A contemporary analysis

series ordinal

7

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men

series ordinal

8

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Insignificant prostate cancer and active surveillance: from definition to clinical implications

series ordinal

9

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly

series ordinal

10

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Ki67 labelling index: an independent predictor of progression in prostate cancer treated by radical prostatectomy

series ordinal

11

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Ki67 labeling index in core needle biopsies independently predicts tumor-specific survival in prostate cancer

series ordinal

12

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Androgen receptor, Ki67, and p53 expression in radical prostatectomy specimens predict treatment failure in Japanese population

series ordinal

14

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Molecular markers of outcome after radiotherapy in patients with prostate carcinoma: Ki-67, bcl-2, bax, and bcl-x

series ordinal

16

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Molecular markers and mortality in prostate cancer

series ordinal

17

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens

series ordinal

18

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis

series ordinal

19

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer.

series ordinal

21

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Prostate cancer detection among men with prostate specific antigen levels of 2.5 to 4.0 ng/ml in a Japanese urological referral population

series ordinal

24

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years

series ordinal

25

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Radical prostatectomy findings in patients in whom active surveillance of prostate cancer fails

series ordinal

26

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study.

series ordinal

27

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Prognostic value of DNA ploidy, bcl-2 and p53 in localized prostate adenocarcinoma incidentally discovered at transurethral prostatectomy

series ordinal

28

1 reference

stated in

Crossref

DOI

10.1093/JJCO/HYQ233

reference URL

https://api.crossref.org/works/10.1093/JJCO/HYQ233

retrieved

22 November 2024

Identifiers

DOI

10.1093/JJCO/HYQ233

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

PubMed publication ID

21233104

1 reference

stated in

Europe PubMed Central

PubMed publication ID

21233104

retrieved

12 May 2018

reference URL

http://europepmc.org/abstract/MED/21233104

ResearchGate publication ID

49753638

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53160720&oldid=2278165571"